Rapilysin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rapilysin, covering 2023-06-01 to 2023-06-01. Get the full timeline:
Most recent: EMA Authorised: Rapilysin (reteplase) — Actavis Group PTC ehf
1 regulatory and trial event tracked for Rapilysin, covering 2023-06-01 to 2023-06-01. Get the full timeline:
Most recent: EMA Authorised: Rapilysin (reteplase) — Actavis Group PTC ehf